Ionis Pharmaceuticals Stock Price on April 29, 2024
| IONS Stock | USD 37.01 0.98 2.58% |
Below is the normalized historical share price chart for Ionis Pharmaceuticals extending back to May 17, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ionis Pharmaceuticals stands at 37.01, as last reported on the 13th of December 2024, with the highest price reaching 38.17 and the lowest price hitting 36.84 during the day.
If you're considering investing in Ionis Stock, it is important to understand the factors that can impact its price. Ionis Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0599, which attests that the entity had a -0.0599% return per unit of risk over the last 3 months. Ionis Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ionis Pharmaceuticals' Risk Adjusted Performance of (0.05), market risk adjusted performance of (0.20), and Standard Deviation of 2.2 to validate the risk estimate we provide.
At this time, Ionis Pharmaceuticals' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 2.3 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 83.9 M in 2024. . At this time, Ionis Pharmaceuticals' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 15.60 in 2024, whereas Price Earnings Ratio is likely to drop (20.77) in 2024. Ionis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of May 1991 | 200 Day MA 42.2682 | 50 Day MA 37.652 | Beta 0.392 |
Ionis |
Sharpe Ratio = -0.0599
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IONS |
Estimated Market Risk
| 2.14 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ionis Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ionis Pharmaceuticals by adding Ionis Pharmaceuticals to a well-diversified portfolio.
Price Book 9.0548 | Enterprise Value Ebitda (22.08) | Price Sales 7.4695 | Shares Float 156.6 M | Wall Street Target Price 61.198 |
Related Headline
Halozyme Therapeutics Headline on 29th of April 2024
Acquisition by Duncan Barbara Gayle of 6501 shares of Halozy... by Duncan Barbara Gayle
Filed transaction by Halozyme Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Ionis Pharmaceuticals Valuation on April 29, 2024
It is possible to determine the worth of Ionis Pharmaceuticals on a given historical date. On April 29, 2024 Ionis was worth 41.73 at the beginning of the trading date compared to the closed value of 41.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ionis Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Ionis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ionis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ionis Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 41.75 | 42.28 | 41.36 | 41.59 | 556,093 | |
04/29/2024 | 41.73 | 42.37 | 41.63 | 41.99 | 709,859 |
| 41.78 | 42.06 | 41.23 | 41.26 | 843,391 |
| Backtest Ionis Pharmaceuticals | | | Ionis Pharmaceuticals History | | | Ionis Pharmaceuticals Valuation | Previous | Next |
Ionis Pharmaceuticals Trading Date Momentum on April 29, 2024
| On April 30 2024 Ionis Pharmaceuticals was traded for 41.26 at the closing time. The top price for the day was 42.06 and the lowest listed price was 41.23 . The trading volume for the day was 843.4 K. The trading history from April 30, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.74% . The trading delta at closing time against the current closing price is 4.36% . |
Ionis Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Ionis Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ionis Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ionis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ionis Pharmaceuticals Stock history
Ionis Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ionis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ionis Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ionis Pharmaceuticals stock prices may prove useful in developing a viable investing in Ionis Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 143.2 M | 83.9 M | |
| Net Loss | -242.7 M | -230.6 M |
Ionis Pharmaceuticals Quarterly Net Working Capital |
|
Ionis Pharmaceuticals Stock Technical Analysis
Ionis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ionis Pharmaceuticals Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Ionis Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ionis Pharmaceuticals December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Ionis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ionis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ionis Pharmaceuticals stock market strength indicators, traders can identify Ionis Pharmaceuticals entry and exit signals to maximize returns
Ionis Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ionis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Ionis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ionis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.